Thus, GHRH agonist, JI-38, has been shown to stimulate both cardiac myocyte and cardiac stem cell proliferation and survival in vitro; animals treated by GHRH agonists showed substantially improved cardiac performance and reduced infarct size after myocardial infarction [16-18]. The gene discussed is GHRH; the disease is myocardial infarction.